Investments
121Portfolio Exits
31Funds
2About HealthCap Venture Capital
HealthCap is a family of multi stage venture capital funds, investing globally in life sciences. We have raised more than EUR 900 million since 1996 making HealthCap one of the largest specialized providers of venture capital within life sciences in Europe.
HealthCap Venture Capital Headquarter Location
18 Avenue D’Ouchy
Lausanne, CH-1006,
Switzerland
41 21 614 3500
HealthCap Venture Capital Investments
121 Investments
HealthCap Venture Capital has made 121 investments. Their latest investment was in Precirix as part of their Series B on March 3, 2022.
HealthCap Venture Capital Investments Activity
Date | Round | Company | Amount | New? | Co-Investors | Sources |
|---|---|---|---|---|---|---|
3/16/2022 | Series B | Precirix | $87.92M | No | BioMedPartners, Forbion Capital Partners, Gimv, INKEF Capital, Jeito Capital, Novo Holdings, Pontifax, Undisclosed Investors, and V-Bio Ventures | 7 |
3/10/2022 | Series A - II | HelloBetter | $4.4M | No | 5 | |
12/23/2021 | Unattributed VC - II | Oncorena | $7.26M | No | FSG Fond, and Linc Invest | 5 |
11/5/2021 | Series B | |||||
10/27/2021 | Series A |
Date | 3/16/2022 | 3/10/2022 | 12/23/2021 | 11/5/2021 | 10/27/2021 |
|---|---|---|---|---|---|
Round | Series B | Series A - II | Unattributed VC - II | Series B | Series A |
Company | Precirix | HelloBetter | Oncorena | ||
Amount | $87.92M | $4.4M | $7.26M | ||
New? | No | No | No | ||
Co-Investors | BioMedPartners, Forbion Capital Partners, Gimv, INKEF Capital, Jeito Capital, Novo Holdings, Pontifax, Undisclosed Investors, and V-Bio Ventures | FSG Fond, and Linc Invest | |||
Sources | 7 | 5 | 5 |
HealthCap Venture Capital Portfolio Exits
31 Portfolio Exits
HealthCap Venture Capital has 31 portfolio exits. Their latest portfolio exit was Min Doktor on November 19, 2020.
Date | Exit | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Acquirer | Sources |
|---|---|---|---|---|---|
11/19/2020 | Acq - Fin | 3 | |||
10/1/2020 | IPO | Public | 1 | ||
6/26/2020 | IPO | Public | 7 | ||
Date | 11/19/2020 | 10/1/2020 | 6/26/2020 | ||
|---|---|---|---|---|---|
Exit | Acq - Fin | IPO | IPO | ||
Companies | |||||
Valuation | |||||
Acquirer | Public | Public | |||
Sources | 3 | 1 | 7 |
HealthCap Venture Capital Fund History
2 Fund Histories
HealthCap Venture Capital has 2 funds, including HealthCap VIII.
Closing Date | Fund | Fund Type | Status | Amount | Sources |
|---|---|---|---|---|---|
9/11/2019 | HealthCap VIII | $209.28M | 1 | ||
6/28/2016 | HealthCap VII |
Closing Date | 9/11/2019 | 6/28/2016 |
|---|---|---|
Fund | HealthCap VIII | HealthCap VII |
Fund Type | ||
Status | ||
Amount | $209.28M | |
Sources | 1 |
HealthCap Venture Capital Team
3 Team Members
HealthCap Venture Capital has 3 team members, including current Managing Partner, Bjorn Odlander.
Name | Work History | Title | Status |
|---|---|---|---|
Bjorn Odlander | Managing Partner | Current | |
Mårten Steen | Merck Serono, and Novo Nordisk | Managing Partner | Current |
Laura Tadvalkar | General Partner | Current |
Name | Bjorn Odlander | Mårten Steen | Laura Tadvalkar |
|---|---|---|---|
Work History | Merck Serono, and Novo Nordisk | ||
Title | Managing Partner | Managing Partner | General Partner |
Status | Current | Current | Current |
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.